Skip to content

Effects of LH Supplementation on Ovulation Stimulation Outcomes in Patients with Ovarian Endometriosis

Impact of LH Supplementation on Clinical Outcomes of GnRH Agonist Long Protocol in Ovarian Endometriosis Patients: A Metabolomic Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092336
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group 1:From the day of gonadotropin initiation, ovarian stimulation was performed using recombinant FSH in combination with LH preparations (including recombinant LH or human menopausal gonadotropin)
Group 2:From the day of gonadotropin initiation, ovarian stimulation was performed using recombinant FSH

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 45 years or younger, scheduled to undergo their first or second IVF/ICSI cycle with GnRH agonist long protocol; (2) Ovarian endometriotic cysts confirmed by radiological examination with a maximum diameter =1.2ng/ml or AFC>=5; (4) BMI<=30kg/m².

Exclusion criteria

Exclusion criteria: (1) History of >=2 failed IVF/ICSI attempts, recurrent spontaneous abortion (RSA), or repeated implantation failure (RIF); (2) Presence of moderate to severe hydrosalpinx, or conditions preventing fresh embryo transfer such as endometrial polyps; (3) Couples with chromosomal numerical/structural abnormalities or monogenic disorders requiring preimplantation genetic testing (PGT).

Design outcomes

Primary

MeasureTime frame
Metabolomics;Serum LHestradiol and progesterone Level ;

Secondary

MeasureTime frame
Assisted Reproductive Technology (ART) Outcomes;Ongoing pregnancy rate;Follicular Output Rate;Follicle-To-Oocyte Index;fertilization rate;implantation rate;Biochemical pregnancy rate;Clinical pregnancy rate;Live birth rate;Number of oocytes retrieved;number of MII oocytes;Number of transferrable embryos;Number of high-quality embryos;Number of fresh embryo transfers;Endometrial thickness on embryo transfer day;pregnancy loss;ectopic pregnancy;pregnancy complications;

Countries

China

Contacts

Public ContactDiao Feiyang

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

phenix_y@163.com+86 138 0158 3408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026